News | April 16, 2024
Moderna pauses plan to build mRNA manufacturing facility in Kenya
The demand in Africa for COVID-19 vaccines has declined
The demand in Africa for COVID-19 vaccines has declined
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Subscribe To Our Newsletter & Stay Updated
